GTR Home > Tests > Search results - C2751682[DISCUI]

Apply filters

Showing tests for all 1014 conditions

Compare labs

  • Hide states

GTR test search results for C2751682[DISCUI]

C Clinical test, R Research test

Showing 1 to 15 of 15 tests for 1014 conditions in 8 labs

CCentoICU platinum

Lab: Centogene AG - the Rare Disease Company University of Rostock Rostock, Mecklenburg-Vorpommern, Germany
Total conditions (769)
Total targets (514)

CCentoICU platinum plus

Lab: Centogene AG - the Rare Disease Company University of Rostock Rostock, Mecklenburg-Vorpommern, Germany
Total conditions (769)
Total targets (514)

CHereditary Neuroblastoma and congenital Central Hypoventilation Syndrome via the PHOX2B Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CInvitae Nervous System/Brain Cancer Panel

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (35)
Total targets (31)

CInvitae Multi-Cancer Panel

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (139)
Total targets (79)

CCongenital Central Hypoventilation NGS Panel

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (14)
Total targets (6)

CCancer Predisposition

Lab: Asper Biotech Asper Biotech Ltd. Tartu, Tartumaa, Estonia
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (127)
Total targets (89)

CPHOX2B

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CHereditary Cancer Syndrome: Sequencing Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (106)
Total targets (45)

CPulmonary Disease: Comprehensive Sequencing Panel

Total conditions (72)
Total targets (53)

CCongenital Central Hypoventilation Syndrome: Sequencing Panel

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (11)
Total targets (7)

CCentral Hypoventilation Syndrome NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (14)
Total targets (6)

CLung Disorders NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (86)
Total targets (51)

CHypoventilation Syndrome NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (9)
Total targets (5)

CNeuroblastoma -Sequence Analysis for ALK Ex 21-28 & PHOX2B Ex 1-3

Test targets
Methods
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

Showing 1 to 15 of 15 tests for 1014 conditions in 8 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.